Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis

Journal of Critical Care

Volumn 30, Issue 4, 2015, Pages 732-738

  Lin, Su ^a   Huang, Zhongtao ^a   Wang, Mingfang ^a   Weng, Zhiyuan ^a   Zeng, Dawu ^a   Zhang, Yanliang ^b   Zhu, Yueyong ^a   Jiang, Jiaji ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bacterial sepsis; Cirrhosis; Interleukin 6; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CYTOKINE; PROCALCITONIN; CALCITONIN; INTERLEUKIN 6; PROTEIN PRECURSOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIUM IDENTIFICATION; BILIARY TRACT INFECTION; BLOOD CULTURE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; FEVER; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; PNEUMONIA; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY TRACT INFECTION; VALIDATION STUDY; BACTEREMIA; BLOOD; COMPLICATION; EVALUATION STUDY; MIDDLE AGED;

ADULT; AGED; BACTEREMIA; BIOMARKERS; CALCITONIN; EARLY DIAGNOSIS; FEMALE; FEVER; HUMANS; INTERLEUKIN-6; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84930760171     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2015.03.031     Document Type: Article

References (36)

1. Fernandez J., Navasa M., Gomez J., et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002, 35(1):140-148.
2. Arvaniti V., D'Amico G., Fede G., et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010, 139(4):1246-1256.e1245.
3. Plessier A., Denninger M.H., Consigny Y., et al. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int 2003, 23(6):440-448.
4. Foreman M.G., Mannino D.M., Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003, 124(3):1016-1020.
5. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
6. Kumar A., Zarychanski R., Light B., et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 2010, 38(9):1773-1785.
7. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34(6):1589-1596.
8. Pfafflin A., Schleicher E. Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem 2009, 393(5):1473-1480.
9. Li C.H., Yang R.B., Pang J.H., et al. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department. Acad Emerg Med 2011, 18(2):121-126.
10. Park W.B., Lee K.-D., Lee C.S., et al. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis. Diagn Microbiol Infect Dis 2005, 51(4):227-230.
11. Fernandez J., Gustot T. Management of bacterial infections in cirrhosis. J Hepatol 2012, 56(Suppl. 1):S1-S12.
12. Dahaba A.A., Metzler H. Procalcitonin's role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator?. Minerva Anestesiol 2009, 75(7-8):447-452.
13. Meisner M., Müller V., Khakpour Z., et al. Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock 2003, 19(2):187-190.
14. Castell J.V., Gomez-Lechon M.J., David M., et al. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990, 12(5):1179-1186.
15. van Rossum A.M., Wulkan R., Oudesluys-Murphy A. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004, 4(10):620-630.
16. Müller B., Becker K.L., Schächinger H., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28(4):977-983.
17. Uusitalo-Seppala R., Koskinen P., Leino A., et al. Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6. Scand J Infect Dis 2011, 43(11-12):883-890.
18. Steinberger E., Hofer N., Resch B. Cord blood procalcitonin and Interleukin-6 are highly sensitive and specific in the prediction of early-onset sepsis in preterm infants. Scand J Clin Lab Invest 2014, 74(5):432-436.
19. Haasper C., Kalmbach M., Dikos G.D., et al. Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. Technol Health Care 2010, 18(2):89-100.
20. Byl B., Roucloux I., Crusiaux A., et al. Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 1993, 104(5):1492-1497.
21. Wang S.S., Lee F.Y., Chan C.C., et al. Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection. Clin Sci (Lond) 2000, 98(4):419-425.
22. Fujimoto M., Uemura M., Nakatani Y., et al. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 2000, 24(4 Suppl.):48S-54S.
23. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655.
24. Buck C., Bundschu J., Gallati H., et al. Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 1994, 93(1):54-58.
25. BalcI C., Sungurtekin H., Gürses E., et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2002, 7(1):85-89.
26. DaSilva O., Hammerberg O. Diagnostic value of leukocyte indices in late neonatal sepsis. Pediatr Infect Dis J 1994, 13(5):409-411.
27. Le Moine O., Deviere J., Devaster J.M., et al. Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol 1994, 20(6):819-824.
28. Wunder C., Eichelbronner O., Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 2004, 53(4):158-163.
29. Oda S., Hirasawa H., Shiga H., et al. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005, 29(4):169-175.
30. Navasa M., Follo A., Filella X., et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998, 27(5):1227-1232.
31. Rosenbloom A.J., Pinsky M.R., Bryant J.L., et al. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. JAMA 1995, 274(1):58-65.
32. Giannoudis P.V., Harwood P.J., Loughenbury P., et al. Correlation between IL-6 levels and the systemic inflammatory response score: can an IL-6 cutoff predict a SIRS state?. J Trauma Inj Infect Crit Care 2008, 65(3):646-652.
33. Panacek E.A., Kaul M. IL-6 as a marker of excessive TNF-α activity in sepsis. Sepsis 1999, 3(1):65-73.
34. Guirao X., Lowry S.F. Biologic control of injury and inflammation: much more than too little or too late. World J Surg 1996, 20(4):437-446.
35. Cazzaniga M., Dionigi E., Gobbo G., et al. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol 2009, 51(3):475-482.
36. Acevedo J., Fernández J., Prado V., et al. Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death. Hepatology 2013, 58(5):1757-1765.